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1. Introduction 
Osteoporosis – the commonest age-related skeletal chronic disorder– is characterized by loss 
of bone mass, alterations of bone micro-architecture, and increased fracture risk. It has, 
however, received much less attention than most chronic diseases. Osteoporotic fractures 
are expensive to treat, and cause significant mortality, morbidity, and loss of independence 
in an ever broader population of patients. As we have said, osteoporosis is a disease in 
which the mineral density of the bone (BMD) is reduced, its microarchitecture disrupted, 
and the expression profile of non-collagenous proteins altered. All these factors predispose 
bones to fractures, particularly the hip, spine and wrist, and are a major cause of disability, 
severe back pain and deformity. The World Health Organization estimates that 
approximately 70 million people worldwide have osteoporosis (Penrod J. et al., 2008). The 
total cost of osteoporosis is difficult to calculate because it includes in-patient and out-
patient medical care, loss of working days, chronic nursing-home costs, and medication. The 
direct costs of osteoporosis arise mainly from the management of patients with hip 
fractures. Hip fractures also account for 40% of all deaths from trauma in patients over 75, 
with 68% of all patients not returning to their former level of activity following an 
osteoporotic hip fractures. The annual worldwide incidence of hip fracture is 1.5 million, a 
number projected to grow to 2.6 million by 2025 and to 4.5 million by 2050 (Penrod J. et al., 
2008). For these reasons, it is necessary to pay a special attention to these health problems 
which disturb the quality of life. 
1.1 Evidence for genetic variation influencing fractures 
Both disease prevention and innovation in therapy are critically dependent on identifying 
the factors that predispose to the development of osteoporosis (Marini & Brandi, 2010). 
Several studies that have investigated the influence of genetic factors on the development of 
osteoporosis have found a weaker contribution than to peak bone mass where up to 80% of 
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the variance can be explained by genetics alone in both sexes (Ralston & de Crombrugghe, 
2006). 
High-throughput technologies facilitate the identification of genetic, genomic, proteomic, 
and metabolomic markers of osteoporosis risk that may find a place in clinical prediction 
algorithms. The operation of intricate networks of genes, environmental factors, and gene-
by-environmental interactions further complicate our understanding of the genetic 
components of the osteoporosis. Until recently, single nucleotide polymorphisms (SNPs) 
were thought to be the predominant form of genomic variation and to account for 
phenotypic variation in patients with osteoporotic disorders and those without. However, 
with the advent and application of array-based comparative genomic hybridization (aCGH), 
which allows analysis of the genome with a significantly higher resolution than previously 
possible, scientists have demonstrated that humans are much more genetically variable than 
previously thought. In two different publications in 2004 (Iafrate et al., 2004; Sebat et al., 
2004) hundreds of genomic regions that varied significantly with respect to the number of 
copies (CNVs) have been reported. Since then, older observations (Iafrate et al., 2004; Sebat 
et al., 2004) have been replicated and expanded (Conrad et al., 2006; deVries et al., 2005; 
Repping et al., 2006; Schoumans et al., 2005; Sharp et al., 2005; Tuzun et al., 2005). CNVs 
vary greatly in size, with insertions or deletions ranging from below 1 kb to several Mb in 
length (Feuk et al., 2006). As with other types of genetic variation, some gene CNVs have 
been associated with susceptibility or resistance to disease (Aitman et al., 2006; Cappuzzo et 
al., 2005; Feuk et al., 2006; Gonzalez et al., 2005; Redon et al., 2006; Sebat et al., 2007; Deng et 
al., 2010). In humans, CNVs encompass more DNA than SNPs and may be responsible for a 
substantial part of human phenotypic variability and disease susceptibility (Freeman et al., 
2006; Redon et al., 2006). In spite of revolutionary technologies, the major genes determining 
the bone density and the fracture risk in humans remain uncertain. Approximately 150 
candidate genes that might influence the BMD have been identified (Richards et al., 2009; 
Zhang et al., 2010). Confirmation analyses have revealed that only 30 of these SNPs are 
somehow connected with the development of osteoporosis. 
Preliminary Pathway analysis (Molecular INTeraction database) of the differentially 
regulated genes/proteins in patients with osteoporosis (Richards et al., 2009) has revealed 
significance for the highlighted nodes (Mothers against decapentaplegic homolog (SMAD) 2, 
3, 4 and 7, Tumor necrosis factor superfamily (TNFRSF), Integrin beta-3 (ITGB3), Bone 
morphogenetic proteins (BMPs), Transforming growth factor beta-receptors (TGFBRs), 
Calmodulin 3 (CALM3), TANK protein, Cystic fibrosis transmembrane conductance 
regulator (CFTR), Pro-neuropeptide Y (NPY)), suggesting that these pathways might play a 
concomitant role in the pathogenesis of osteoporosis (Fig. 1). New findings notwithstanding, 
we have to remember that the formation of bone and its repair is a complex process 
including skeletal patterning, remodeling, and bone growth. The rate of bone formation is 
dependent on the commitment and replication of several cell types, including 
osteoprogenitor cells. Their differentiation into functional osteoblasts and the life span of 
mature osteoblasts is very important. Although a few signaling pathways and patterns of 
gene expression have been identified in the process of osteoblast differentiation, the exact 
molecular mechanisms are poorly understood. 
A recent genome wide association study (GWAS) has identified approximately 9000 CNVs 
in patients with lower BMD at spine, hip, and femoral neck (Deng et al., 2010). This study 
showed that only one low copy number variant of VPS13B gene had some possible 
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Fig. 1. Overview of signal-transduction pathways associated with candidate genes 
underlying susceptibility to osteoporosis. 
protective role associated with stronger bones and reducing the risk of osteoporotic 
fractures. The extent to which genes cause alteration in combination with different risk 
factors for fracture might explain the incidence of fractures in the population, and will 
depend on strength of association between the risk factor and fracture risk, and on 
proportion of the population at different levels of allele frequencies (Hopper, 2000). 
Therefore, although a variation in a risk factor may be strongly genetically determined, it 
may have little consequence for the disease in terms of explaining different patient’s clinical 
outcomes.  
2. State-of-the-art 
Bone fracture healing is a complicated, multistage process, influenced by cells events and 
regulated by local and systematic factors. Recent data concerning the regulatory factors 
correlated with fracture healing suggest that several chemical compounds can be used to 
stimulate bone growth, and enhance callus formation and maturation. The pharmacological 
approach towards osteoporosis prevention aims to increase the bone mass by decreasing of 
osteoclastic bone resorption with the aid of estrogens, bisphosphonates, calcitonin, calcium 
plus, cholecalciferol, calcitriol and selective estrogen receptor modulators (Grabo & 
Longyhore, 2008). 
Moving away from these conventional approaches, investigators have recently used 
lovastatin loaded nanoparticles (Garrett et al., 2007) or Ossein – Hydroxyapatit compounds 
(OHC) for osteoporosis treatment. One of the most important pleiotropic actions of statins is 
their effect on bone metabolism (Horiuchi & Maeda, 2006). Statins form a class of 
hypolipidemic agents, known as 3-hydroxy-3-methylglutaryl coenzyme A (HMG Co-A) 
reductase inhibitors, commonly used as therapy to lower the cholesterol levels in people 
with/or at risk of cardiovascular disease. Statins exhibit a pleiotropic effect in preclinical 
models, accelerating fracture healing and increasing angiogenesis when the fracture area is 
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systemically or locally treated. OHCs also have osteogenic and chondrogenic properties in 
vitro and accelerate fracture healing in vivo (Annefeld et al., 1986).  
Some patients respond poorly to these therapies, including the integration of implants such 
as hip replacements. They develop post-surgical complications, caused mainly by 
weakening of the implant-bone bond due to bone resorption at the interface. This is caused 
by necrosis of the surrounding host tissue due to surgery, heat released during cement 
polymerization and micromotion caused by poor fixation. To improve the integration of 
implants with weak osteoporotic bone, fixation augmentation techniques have been recently 
proposed such as superficial coatings of polymethylmethacrylate, calcium phosphate 
ceramics or hydroxyapatite (HA) onto the metallic surfaces (Annefeld et al., 1986; Moroni et 
al., 2001; Moroni et al., 2005a; Moroni et al., 2005b). Metal surfaces coated with 
nanohydroxyapatite or biomimetic calcium phosphate (CaP) have been used to improve the 
fracture fixation stability, which has been proposed as a strategy for porous bones. 
However, the conventional method for CaP-coating requires high temperature treatment, 
which prevents the addition of bioactive pharmaceuticals. Post-treatment loading with 
drugs generally results in their uncontrolled, high kinetic release. A biomimetic nano-CaP 
coating technology which retains all the features of plasma spraying, including controllable 
porosity and 3D morphology was recently developed. This technology results in the 
deposition of amorphous CaP coprecipitated with bioactive substances through the full 
thickness of the coating, allowing gradual release. The influence of resorbable CaP particles 
and paste on bone healing was investigated by Bloemers et al. (Bloemers et al., 2003). 
Twelve weeks after the defect reconstruction, radiological, biomechanical, and histological 
analyses were performed. Biomechanical tests showed a significantly higher torsional 
stiffness for the resorbable CaP paste group when compared with the autologous bone. 
Several other investigations (de Melo et al., 2006; Niemeyer et al., 2010) published recently 
utilized the transplantation of xenogenic human and autologous ovine mesenchymal 
progenitor cells in an ovine critical-size defect or study whether blood-derived endothelial 
progenitor cells promote the bone regeneration once transplanted into an ovine and tibial 
defect in animal models (Rozen et al., 2009). Both studies showed significant bone 
regenerative processes, but the overall results are inconclusive. 
Nanoscale materials currently investigated for bone tissue engineering applications can be 
placed in the following categories: ceramics, metals, and composites. Each type has distinct 
properties that can be advantageous for specific bone repairing applications. For example, 
HA, an inorganic compound of bone can be made synthetically. Ceramics are not 
mechanically tough enough to be used in bulk for large scale bone fractures. However, for a 
long time they have found applications as bioactive coatings, owing to their ionic bonding 
mechanisms that are favorable for osteoblast functions (Hench, 1982; Hench, 2004). Unlike 
ceramic materials, metals are not present in the body as bulk materials. However, because of 
their mechanical strength and relative inactivity with biological substances, metals and 
alloys (Ti, Ti6Al4V, CoCrMo, etc.) have been the materials of choice for large bone fractures. 
Composites of the above mentioned materials can be synthesized to provide a wide range of 
material properties and also to increase the bone implant performance (Nikolovski & 
Mooney, 2000). It was found that detonation-generated nanodiamond (DND) inclusions can 
stimulate the biological performance of the composite layer (Pramatarova et al., 2007). 
Although novel bioactive and organic materials with good bioavailability and osteogenic 
activity such as new nano CaP and sulfate cements, bioactive glass and polymers, have been 
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developed in last years, their application in the treatment of osteoporotic bones is limited 
because of their weak angiogenic properties.  
3. New concepts and strategies for the treatment of osteoporosis 
A significant number of osteoporotic bone fractures are treated with implants which are 
generally fixed with bone cement. However, this fixation requires good quality cancellous 
bone, generally absent in the osteoporotic population. The incidence of implant loosening 
and revision surgery is high when osteoporosis is present. For years, attempts have been 
made to use tissue engineering to develop functional substitutes for damaged or diseased 
tissues through complex constructs with living cells, bioactive molecules and three-
dimensional scaffolds, which can support cell attachment, proliferation and differentiation. 
By integrating of nanotechnology with cellular and molecular biology we aimed to develop 
injectable, bioresorbable polymers, in acellular and autologous cell-seeded forms, to enhance 
the bone fracture fixation and healing, and to promote regeneration of the natural tissue. 
New strategies involve: 
• Preparation of injectable scaffolds  
- Incorporation of angiogenic/osteogenic factors within the scaffolds (if necessary)  
- Homogeneous distribution within a cavity of any shape  
- Easy integration of biologically active substances and nanomaterials for 
improvement of the pro-angiogenetic properties of bone macroporous scaffolds  
- The ability to deliver progenitor cells as autologous transplant 
- Manipulation of cell function 
- Avoidance of foreign body reactions 
- Transplant assimilation and remodelling 
• Preparation of implants with tailored properties 
- Enhancing minimally invasive application and securing better apposition between 
bone tissue and material  
- Deposition of angiogenic extracellular matrixes on the surfaces 
- Preparation of new implants with increased biocompatibility by specific 
nanocoating technology. 
Strategies that allow efficient scaffold injectability are critical for the realization of successful 
treatment for osteoporosis with minimally invasive surgery.  
4. Methods 
4.1 Synthesis of PLGA-PEG-PLGA triblock copolymers 
The synthesis of block copolymers with a general structure PLGA-PEG-PLGA was 
accomplished as follows: A mixture of polyethylene glycol (PEG), lactide and glycolide with 
a predetermined molar ratio (Table 1) was placed into a polymerization flask and dried by 
azeotropic distillation using anhydrous toluene as an entraining agent. After heating at  
80 °C under stirring, 0.5 mL of 0.06 M Sn(Oct)2 was rapidly injected through a septum into 
the polymerization mixture. Then the reaction temperature was elevated to 140 °C and 
maintained constant for 24 hours. After that, the polymerization flask was cooled down to 
room temperature and the reaction mixture was dissolved in a small amount of CH2Cl2. The 
copolymers were collected by precipitation in cooled diethyl ether and dried at 40 °C in 
vacuum for few minutes. The obtained copolymers were dissolved in cold water and then 
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heated to 80 ºC to precipitate, and remove the water-soluble impurities and unreacted 
polyethylene oxide. The purification process was repeated three times.  
 
Sample Lactide, g Glycolide, g PEG, g Yield,% 
PLGA1000-PEG1000-PLGA1000 8.352 1.665 5.000 97 
PLGA900-PEG1000-PLGA900 7.500 1.499 5.000 93 
PLGA800-PEG1000-PLGA800 6.665 1.330 5.000 98 
PLGA700-PEG1000-PLGA700 5.832 1.165 5.000 87 
Table 1. The starting monomer and oligomer amounts for the synthesized block copolymers 
and their yields. 
The polymers were characterized by 1H NMR (250 MHz) spectroscopy recorded with a 
Bruker Avance DRX 250 apparatus, Fourier transforms infrared (FTIR) spectroscopy, and 
Size exclusion chromatography (GPC). GPC was performed on Waters chromatographic 
system, equipped with a double detection- differential refractometer M410 and M484 UV 
detector. Data collection and processing were done using Clarity software. The analyses 
were performed on Ultrastyragel Linear, Styragel 100 Å, and Styragel 500 Å columns 
(Waters) calibrated with polyethylene oxide (PEO) standards. Tetrahydrofuran was used as 
mobile phase with a flow rate of 1.0 ml/min at 45 °C. FTIR spectra (KBr pallets) were 
recorded on Bruker-Vector 22 FTIR spectrometer at a resolution of 1-2 cm-1 accumulating 50 
scans. 
4.2 Nanocrystalline diamonds production and characterization 
Shock-wave synthesis was used to produce nanocrystalline diamonds (NCDs) by explosive 
conversion of a trinitrotoluene/hexogene mixture with negative oxygen balance (Ivanova et 
al.,  2011). A water-cooled combustion chamber with 3.0 m3 volume was applied. A mixture 
of diamond blends containing 85% NCDs was obtained. The NCDs were purified by 
oxidative removal of the non-diamond carbon using a mixture of K2Cr2O7 and H2SO4 
according to (Tsoncheva et al., 2006). NCDs were characterized by X-ray diffraction (XRD), 
transmission electron microscopy (TEM), and energy dispersive X-ray spectroscopy (EDS). 
The XRD spectra were obtained with a Bruker D2Phaser diffractometer with CuKα radiation 
in 2 theta range between 30 and 110° with a step of 0.02° and a measuring time of 10 s per 
point. The size and morphology of NCDs were studied by TEM. The experiments were 
performed with a Philips EM420 transmission electron microscope with accelerating voltage 
of 120 kV. The sample was suspended by ultrasonic agitation in ethanol at room 
temperature and an aliquot of the solution was dropped on a holey carbon film supported 
on a copper grid. The impurities present in the samples were analyzed with an EDAX 
9100/70 attached to the microscope.  
4.3 Preparation of polymer hydrogels and its lovastatin and NCD loaded forms 
The polymer hydrogels were obtained by dissolving of the PLGA-PEG-PLGA polymers in 
deionized water at suitable temperatures - below and above the so-called “gelation 
temperature”. Equal amounts of freeze-dried PLGA-PEG-PLGA polymers were dissolved in 
different amounts of sterile water to prepare samples with desired concentrations (10, 15, 20, 
and 25% (w/w)). The total solubility of the copolymers was achieved by continuous shaking of 
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the samples at a temperature of 4.0 °C for 48 h. The gel-sol transition behavior of the block 
copolymer solutions was investigated following the procedure described by Lee et al. (Lee et 
al., 2006) using a WB-4MS water bath-thermostat (Biosan) and also was studied by rheological 
analysis (Yu et al., 2010). The introduction of NCDs in the polymer hydrogels was made by 
preparation of sterile aqueous NCD suspensions with different concentrations, used in order 
to get a final concentration of 0.5 mg/ml in the hydrogels. The sterilization of the NCDs was 
achieved through stepwise washing with 99% and 45% ethanol and autoclaved deionized 
water. Lovastatin loaded hydrogels were obtained by dissolution of lovastatin (powder) in the 
already prepared hydrogels. The final concentration of lovastatin was 825 µM. 
4.4 In vitro degradation of the polymeric hydrogels 
The degradation of the polymeric hydrogels (166 µl of 25% (w/w) PLGA1000-PEG1000-
PLGA1000 or PLGA900-PEG1000-PLGA900) was determined by their incubation in the presence 
of 5.0 ml EPCs cell culture media (see below) in 24 well plates, in a humidified 5.0% CO2 
incubator at 37 °C for 10, 20, and 30 days. Following the incubation periods, the cell culture 
media was removed and the remaining hydrogels were washed with distilled H2O several 
times and dried under vacuum up to a constant weight. The obtained dried polymer 
residuals were dissolved in CDCl3 and characterized by 1H NMR spectroscopy. The 
hydrogels degradation was also followed by phase contrast microscopy (Carl Zeiss Teraval 
3) equipped with a DCM 300 digital camera (Hangzhou Huaxin IC Technology Inc., China). 
4.5 Preparation and surface modification of nanodiamond films for implants 
functionalization 
The ultrananocrystalline diamond (UNCD) coatings discussed in this chapter were grown 
by microwave plasma chemical vapour deposition (MWCVD) from gas mixtures containing 
17% CH4 in N2. The substrate temperature was kept 600 °C, the working pressure 2.2 kPa, 
the microwave power 800 W, the deposition time 360 min. Detailed description of the 
MWCVD set-up is given in (Popov et al., 2006b). Monocrystalline silicon wafers were used 
as substrates which were ultrasonically pretreated in a suspension of diamond powders 
with different fractions in n-pentane prior the deposition in order to enhance the diamond 
nucleation on the surface. Such coatings were prepared also on a number of other materials 
of biomedical interest, for example, Ti-alloy used for implants (Kulisch & Popov, 2006). 
In order to tailor the surface properties of the UNCD films with respect to their wettability, 
surface conductivity, etc., they were subjected to a number of surface modification processes as 
follows: i) H2 microwave plasma at 400 °C in the deposition set-up (in the following: HP); ii) O2 
microwave plasma at room temperature (OP); iii) CHF3 plasma in a 13.56 MHz parallel plate 
reactor also at room temperature (FP); iv) NH3/N2 plasma in a 13.56 MHz plasma enhanced 
chemical vapour deposition set-up at room temperature (NP); v) UV/O3 photochemical 
treatment at room temperature (UV) and vi) chemical treatment with aqua regia (HCl/HNO3 
with a ratio of 3:1) at room temperature (AR). Further experimental details can be found in 
several references (Koch et al., 2011; Kulisch et al., 2010; Popov et al., 2008b). 
4.6 Isolation and characterization of endothelial progenitor cells (EPCs) 
Endothelial progenitor cells were isolated and cultured with minor modifications of the 
protocols described in earlier works (Fuchs et al., 2006a; Fuchs et al., 2006b). In brief, 
mononuclear cells were harvested from human peripheral blood buffy coats using Ficoll 
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(Sigma-Aldrich) gradient  centrifugation and cultured in endothelial cell growth medium-2 
(EGM-2 kit; CC-3162, Lonza, Belgium), 5.0% fetal calf serum (FCS; Lonza, Belgium), and 
1.0% penicillin/streptomycin, on collagen-coated (BD Europe, Germany) well plates, where 
5×106 cells per well were seeded. The good colonies of EPCs appeared after 3 to 4 weeks in 
culture. The EPCs’ phenotype characterization was done following the protocol of (Fuchs et 
al., 2006a).  
4.7 Transformation of EPCs to osteoblast 
Two days after colony formation, the EPCs were trypsinized to single cells, passed through 
a 70 µm filter, and plated on 1.0 mm cover slips coated with hydrogels at 25 cells/cm2 in 
osteoprogenitor medium (IMEM, Invitrogen) supplemented with 10% fetal bovine serum 
(Lonza, Belgium), 0.1 mM 2-mercaptoethanol, 2.0 mM Glutamax I, 2.0 mM BMP-2, and 0.2 
mM ascorbic acid. The cultures were fed with osteoprogenitor medium every 2-3 days and 
allowed to differentiate up to 21 days to form mature bone nodules on different substrates. 
The transformation of endothelial phenotype of EPCs into long-term osteoblast culture 
growing on hydrogels or UNCD coatings was assessed as described previously (Popov et 
al., 2008a; Trajkovski et al., 2009) and followed by phase contrast and fluorescent 
microscopy, real time PCR (qPCR) and Western blot (Trajkovski et al., 2009). RNA and 
proteins were isolated with Trisol (Invitrogen, USA) following manufacturer’s instruction 
on Day 1, 7, 14 and 21 after EPCs seeding on hydrogels and nanocomposites. Prior to 
amplification, the RNA purity and integrity were checked on Nanodrop-1000 (Termo-
Scientific) and agarose gel electrophoresis. SYBR Green qPCR analysis was performed on 
RotorGene-6000 (Corbet) with the primers sequences and conditions as described by Woll et 
al (Woll et al., 2006; Woll & Bronson, 2006). 
4.8 In vivo experiments 
This study was carried out in accordance with the guidelines of the Medical University 
Pleven Ethics Committee (N 20/21.12.2010). A total of 24 adult female Wistar rats (220– 250 
g, 3 animals per group) were used. Following i. p. injection of 45 mg/kg b.wt. ketamine a 
sterile 25% (w/w) PLGA1000-PEG1000-PLGA1000 polymers with or without lovastatin (825 µM) 
or nanodiamonds (500 µg/ml) were implanted s. c. The animals were sacrificed on day 1 
and 30 days later, and the explants were taken for further analysis.  
4.9 Statistical analysis 
The data were evaluated by analysis of variance (ANOVA) followed by Tukey’s post-hoc 
test. Differences in the results at the level of p<0.05 were considered statistically significant. 
The statistical analysis was carried out using the PASW 18.0 statistical software package 
(IBM) for Windows.  
5. Results 
The structure-function properties of the native bone tissue pose strong design criteria to the 
substrates required to engineer their living counterparts or to be used in endogenous repair. 
When designing these substrates one should consider the macroscopic (organ level, 
geometry), the microscopic (cell and tissue level, scaffold architecture), and molecular 
properties relevant for tissue morphogenesis and function (e.g. hematopoiesis). In addition, 
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developmental aspects, such as growth, differentiation, migration and maturation should be 
taken into account, as these may dictate substrate properties, like degradation and porosity, 
or require additional instrumentation of bioactive factors (Bouten et al., 2011). Such scaffolds 
with a possible application for in bone injection have to be designed and studied very 
carefully, because the progenitor cells derived from bone marrow may also be homed on to 
the bioactive substrate. 
5.1 Characterization of three-dimensional (3D) scaffolds  
The composition of PLGA-PEG-PLGA block copolymers and its average molecular weight 
(Mn) were determined by 1H NMR spectroscopy (Fig. 2). The broad chemical shift signal at 
3.65 ppm marked as b is a characteristic of the methylene protons of the ethylene oxide 
repeating units. The signals observed at 1.58 ppm (signal a) CH3-CH-, 5.2 ppm (signal d) 
CH3-CH-, and 4.8 ppm (signal c) -O-CH2-C(O)- are assigned to protons of methyl, methine, 
and methylene groups in lactide and glycolide units, respectively. The integrations (Ia, Ib, Ic, 
Id) of the signals observed at 1.58, 3.65, 4.8 and 5.2 ppm assigned above were used for 
calculation of average molecular weight of all block copolymers following the equations: 
 Mn (NMR) = [(Ia/3)MLac + (Ic/2)MGly + MEO] × 4IbDPPEG (1) 
or 
 Mn (NMR) = [(IdMLac + (Ic/2)MGly + MEO] × 4IbDPPEG (2) 
The DPPEG is the degree of polymerization of the PEG block and MLac, MGly and MEO are the 
molecular weights, of the lactic, glycolic, and ethylene oxide segments. The calculated 
values of the average molecular weight of the block copolymers are represented in Table 2. 
 
Sample 
Mn,
(Theor.)
Mn,
(NMR)
Mn,
(GPC)
Mw/Mn , 
(GPC) 
PLGA1000-PEG1000-PLGA1000 3000 3150±122 3300±169 1.25 
PLGA900-PEG1000-PLGA900 2800 2948±151 3140±115 1.17 
PLGA800-PEG1000-PLGA800 2600 2873±177 2700 1.11 
PLGA700-PEG1000-PLGA700 2400 2664±113 2621 1.21 
Table 2. Characteristics of the PLGA-PEG-PLGA triblock copolymers. Data are 
representative from twelve independent syntheses and are expressed as average ± S.D. 
The results showed deviations between the theoretically expected and the experimentally 
calculated molecular masses of all polymers. These deviations could be attributed to the 
presence of some moisture in the organic substances – monomers and PEG oligomer. The 
NMR data and those obtained from the GPC analysis reveal similar values for the molecular 
weight of all polymers. The received dispersity (Mw/Mn) indicates the narrow molecular 
weight distribution(see Table 2), which is typical for polymers prepared by a “living”, 
controlled polymerization. 
The composition of the polymers was also proved by FTIR spectroscopy. The spectra of all 
polymers show similar bands and signals. Only slight differences in the intensity of the 
bands attributed to the ester and ether type bonds at 1760 and 1163 cm-1 were observed and 
referred to the differences between the numbers of monomer units included in the polymer 
chains (data not shown). 
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Fig. 2. Chemical characterization of the polymers. A: 1H NMR spectra of PLGA1000-PEG1000-
PLGA1000 (1) and PLGA900-PEG1000-PLGA900 (2) block copolymers; B: Molecular weight 
distribution overlay patterns of indicated polymers received by gel-permeation 
chromatography. 
The copolymers with an analogous structure but a different ratio between the hydrophilic 
(PEG) and hydrophobic (PLGA) blocks have been an object of considerable scientific interest 
and value. The influence of the hydrophilic/hydrophobic ratio between PEG and PLGA 
blocks, and of the block length on the sol-gel–sol transition properties of PLGA-PEG-PLGA 
triblock copolymers has been reported (Lee et al., 2001). The authors have also found that 
the effects of different intramolecular/micellar behavior are accompanied by drastic 
changes in the area of gel zone.  
5.2 Temperature–induced sol-gel phase transition of PLGA-PEG-PLGA block 
copolymers  
In our work we chose to investigate PLGA-PEG-PLGA copolymers with much lower 
hydrophobic PLGA content (PEG:PLGA = 1:2 ; 1:1.8). The advantages of such hydrogels and 
especially their ability to be loaded with bioactive substances, drugs, cells, nanoparticles and 
etc., prior administration are of particular interests. The phase behavior (reversible sol-gel-
sol transitions) of the obtained block copolymers in aqueous media at different temperatures 
and concentrations are illustrated in Fig. 3. As shown, only PLGA1000-PEG1000-PLGA1000 and 
PLGA900-PEG1000-PLGA900 copolymers possessed the typical gel-sol phase transition 
behavior upon heating. They have the ability to form temperature dependent micellar 
aggregates and after further temperature increase form gels due to micelles aggregation 
and/or packing. In contrast, the other two copolymers showed a vastly different 
performance. As the longer PLGA chains are present, stronger hydrophobic interactions are 
detected, leading to an increase in the aggregation and packing between the polymer 
micelles resulting in the formation of a denser gel state. The gel zone in the phase diagram 
of PLGA800-PEG1000-PLGA800 and PLGA700-PEG1000-PLGA700 copolymers was not found. 
Nevertheless, we observed significant alterations of their viscous properties – changes from 
amber viscous to white viscous state. With additional rise of the temperature, direct 
transition from white viscous to suspension state was also observed. The slight increase in 
the temperature enhances the thermal motion of the hydrophobic chains in the PLGA800-
PEG1000-PLGA800 and PLGA700-PEG1000-PLGA700 copolymers, which may lead to the 
disturbance of the micellar structures and polymer precipitation. 
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Injectable biodegradable copolymer hydrogels, which exhibit a sol–gel phase transition in 
response to external stimuli, such as temperature changes, have found several biomedical 
and pharmaceutical applications, such as drug delivery, cell growth, and tissue engineering 
(Gao et al., 2010; Kan et al., 2005; Kim et al., 2001; Nguyen & Lee, 2010; Qiao et al., 2006; 
Zentner et al., 2001). Such polymers are also biocompatible and biodegradable, and they 
represent an ideal system for treatment, being able to overcome the problem of carrier 
removal after injection (implantation). Hydrogels sensitive to temperature are useful for 
both in vitro and in vivo applications. These applications will strongly depend on hydrogels 
composition and it is important to administer the sol dispersion upon quick transformation 
to gel under physiological conditions. The composition, morphology and crystallinity of the 
block copolymers strongly influence the mechanical properties and rate of degradation 
under specific conditions. To study the in vitro behavior of the PLGA1000-PEG1000-PLGA1000 
and PLGA900-PEG1000-PLGA900 copolymers we used light microscopy and 1H NMR 
spectroscopy.    
 
 
Fig. 3. Sol-gel transitions of PLGA1000-PEG1000-PLGA1000 block copolymer (A) and phase 
diagrams of PLGA-PEG-PLGA triblock copolymers (B). 
5.3 In vitro degradation of the polymeric hydrogels 
Polymer degradation is the key process of erosion and plays a crucial role for all polymers 
studied. The processes involved in the erosion of a degradable polymer are very 
complicated. They can be summarized as follows: (1) water enters the polymer bulk; (2) 
water entrance may be accompanied by swelling; (3) chemical polymer degradation 
appears, leading to the creation of oligomers and monomers.; (4) the degradation changes 
the microstructure of the hydrogels through pore formation; (5) oligomers and monomers 
are released; (6) dissolution and diffusion of oligomers and monomers are undergoing; (7) 
the pH inside the pores can be changed, depending of polymer composition; (8) finally, the 
released oligomers and monomers lead to the weight loss of the hydrogels. 
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Fig. 4 reflects the hydrogels morphology after 10 and 30 days in contact with 5.0 ml EPC 
culture media at 37 °C. The 20 and 25% (w/w) PLGA1000-PEG1000-PLGA1000 and PLGA900-
PEG1000-PLGA900 copolymer samples were about 1.0 mm thick and 1.0 cm in diameter.  
 
 
Fig. 4. Optical microscopic images of the polymeric hydrogels during their destruction in 
cell culture environment. Magnification: x100. 
Changes in the weight-average molecular weight (MW) of PEG and PLGA components in 
the scaffolds as a function of degradation time are shown in Fig. 5. It can be seen that the 
MW of hydrogels decreased with incubation time for all of the scaffolds. There were no 
significant differences in the degradation rate between 20 and 25% hydrogels. The decrease 
in molecular weight can be attributed to hydrolysis and macromolecular scission of PLGA 
(Shih et al., 1996). Monomer release profiles for PLGA have a short induction period. The 
release rate was higher at early times and declines in a concave manner. 
The acidic degradation products of PLGA did not lead to severe decrease in the pH values. 
It drops from 7.4 (Day 1) to 6.4 (Day 30). To evaluate the degradation of the scaffolds, the 
medium pH for the specimens was compared to media that was held under the same 
conditions but did not contain any samples (blank). The EPC’s media with a lower pH than 
the blank one would indicate the release of acidic products from the scaffolds and can lead 
to faster degradation.  
By 24 h the difference between the blank media pH and the pH of the media in contact with 
hydrogels was negligible and remained so through 1 week. On day 10, the pH of the media 
incubated with hydrogels began to decrease. This decrease in pH persisted through week 2 
and 3, with a maximum deviation from blank pH of - 0.94 ± 0.06 at week 4.  
It was noticed that the weight loss was about 39% after 30 days degradation in the cell 
culture media, however, it was 30% just after 10 days. We used the formulas (1) and (2) 
mentioned above to calculate the changes in the hydrogels’ molecular weight - molar 
content of the different co-compounds. It should also be kept in mind, that the obtained 
values are relative and don’t represent actual PLGA and PEG content in the hydrogels or 
overall molecular weight of the polymeric chains, but can be used for the construction of a 
simple qualitative model describing their destruction. Looking at Fig. 5 we can see 
significant changes or decreasing in the content of PEG part in hydrogels i. e. decreasing the 
molecular weight of the corresponding copolymers with the time. Similar indicated changes 
in the hydrophobicity of the polymeric materials of similar type have also been reported by 
(Youxin et al., 1994; Zweers et al., 2004). 
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Fig. 5. The relative change in the composition of the block copolymers with the time. 
Alteration in the molecular weight of PLGA are calculated at a constant PEG content and 
molecular weight. 
The mechanism of erosion/degradation of the polymeric hydrogels can be presented by the 
general scheme shown in Fig. 6. It can be summarized as follow: (1) the amphiphilic PLGA-
PEG-PLGA three-block copolymers form stable micelle solutions; (2) under the influence of 
thermal fluctuations on the polymeric chains, the micelles are packed into a crystalline-like 
structure – hydrogel; (3) the H2O immerges into hydrogels, and the quick swelling happens; 
(4) when the swelling equilibrium is reached, the chains start to break as a function of time; 
(5) the presence of water provokes bulk degradation of the hydrogels via a random 
hydrolytic scission of the ester linkages in the vicinity of PEG; (6) sustained release of water-
soluble PEG and PEG’s end-capped with short PLGA tails; (7) the hydrophobicity of the 
remaining hydrogel should increase; (8) as the experiments were conducted in cell culture 
media with high buffer capacity, the further hydrolysis of glycolic–glycolic and glycolic–
lactic ester bonds by lactic and glycolic acids will be slow down.  
 
 
Fig. 6. Schematic representation of hydrogel formation and erosion/degradation. 
Sol-gel transition characteristics, including transition temperature and gel window width 
are the critical parameters which should be taken into consideration in designing 3D 
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scaffold biomaterials. For in vitro and in vivo application is also necessary to know their 
behavior in surrounding environments. To follow the biochemical and molecular biological 
response of the composites prepared by us we investigated the possibility these polymers to 
be prepared as a cell loaded form.  
5.4 Scaffold colonization and seeding efficiency 
The EPCs’ attachment and differentiation were  performed on sample scaffolds prepared with 
or without NCDs and lovastatin to evaluate the cell biocompatibility. The experiments 
suggested that on day 1 of culturing low number of cells was attached to all scaffolds studied. 
The loading efficiency reached 73.1 ± 5.3% after 3 days on PLGA-PEG-PLGA + NCDs and 
composites with NCDs and lovastatin (89.6 ± 5.7%) and only 11.4 ± 1.5% for the PLGA-PEG-
PLGA + lovastatin. A qualitative analysis of cell adhesion on the scaffolds was carried out by 
phase contrast microscopy up to 21 days. This study (Fig. 7) demonstrated that the cells were 
distributed unequally throughout the surface structure with different morphology at the 
beginning. The results presented in Fig. 7 also confirmed the infiltration and migration of cells 
deep into the 3D porous network on scaffolds containing NCDs or NCDs + lovastatin only. 
Cells with distinct rounded nuclei were observed throughout the scaffold, further suggesting 
normal cell growth on these composites. The results about EPCs adhesion on PLGA-PEG-
PLGA scaffolds can found in (Trajkovski et al., 2009; Ivanova et al., 2011).  
 
 
Fig. 7. Endothelial progenitor cells growing on different type composites based on 25% 
(w/w) PLGA1000-PEG1000-PLGA1000 hydrogel, containing lovastatin and/or nanocrystalline 
diamonds (NCDs). Bars 50 µm. 
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Next we have examined the release of fibronectin (FN) during the EPCs differentiation to 
osteoblast. Fluorescent photomicrographs of FN stained cells are shown on Fig. 8. As it can 
be seen the cell response is heterogeneous and FN distributes in a diffuse, punctate pattern 
of staining throughout the whole surface. The obtained results can be summarized as 
follows: (1) FN release was detected on day 7 and this was connected with its adsorption to 
the surfaces; (2) During the process of EPCs differentiation, the release of FN was favored by 
the hydrogels + NCDs (day 12, 15, and 21). These observations confirmed the hypothesis 
suggesting that FN is adsorbed preferentially on hydrophobic surfaces (Nordahl et al., 
1995), such as the surface of the hydrogels + NCD undergoing erosion. It has also been 
suggested that FN plays a unique role during the differentiation of osteoblast cultures 
connected with the formation of mineralized nodules in vitro (Robey, 1996). We have 
reported results confirming this observation (Ivanova et al., 2011). 
 
 
Fig. 8. Composite induced changes in distribution of fibronectin. Hydrogels were based on 
25% (w/w) PLGA1000-PEG1000-PLGA1000 (A); PLGA1000-PEG1000-PLGA1000 + lovastatin (B); 
PLGA1000-PEG1000-PLGA1000 +nanocrystalline diamonds (C); PLGA1000-PEG1000-PLGA1000 + 
lovastatin + nanocrystalline diamonds (D). The tracings immediately under each panel are 
scans of the pixelated fluorescence intensity of fibronectin integrated vertically and scanned 
horizontally across the magnified field. 
All data obtained by us indicated that not only the PLGA-PEG-PLGA scaffolds are 
biocompatible with the EPCs as reported (Trajkovski et al., 2009; Ivanova et al., 2011), but 
composites with NCDs actually promote their growth and transformation. The processes of 
EPCs differentiation can influence the expression of several important genes. We further 
followed these changes by quantitative real time PCR analyses.  
5.5 qPCR analysis of mRNA derived from endothelial progenitors cells undergoing 
transformation to osteoblasts 
The expression of four osteogenic markers Twist1, Runx2, Osterix, and Bglap1, and the 
endothelial one - platelet endothelial cell adhesion molecule (PECAM1), was analyzed at 
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various time points throughout the transformation of the EPCs culture to osteoblasts. The 
results shown on Fig. 9 revealed a gene expression pattern characteristic of the osteoblast 
differentiation. The expression of Twist1 and Osterix was highly upregulated by day 14 and 
persisted to day 21 without significant differences between scaffolds studied. Runx2 and 
Bgalp1 expression was continuously increasing during the differentiation and it was found 
to be significantly higher (Day 7: p=0.034; Day14: p=0.011; Day 21: p=0.07) in EPCs growing 
on composite scaffolds containing NCDs in comparison with hydrogels ± lovastatin. The 
PECAM-1 was expressed at the beginning of the differentiation process, but decreased on 
days 7 and 21. Incorporation of the lovastatin in hydrogels increased the expression of 
PECAM-1 at day 7 about five times. 
In comparison to the hydrogels ± lovastatin, the scaffolds ± NCDs leaded  to upregulation of 
the osteoblasts associated markers at two time points of investigation (Day 7 and 21). In 
accordance with these observations the total protein amount of Runx2, Osteocalcin and 
Collagen-α1 was also high (Trajkovski et al., 2009). Runx2 mRNA and protein amount were 
found to increase continuously. Their expression is also critical for mature osteoblast function. 
RUNX2 binding sites were identified in the osteoblast specific genes encoding osteocalcin, 
bone sialoprotein, and osteopontin, as well as type I collagen (Ducy et al., 1997). The detected 
earlier expression of Runx2 mRNA might positively influence the latter expression of 
osteocalcin and collagen-α1 observed by us. The registered increase in PECAM1 mRNA 
demonstrated at Day 1 and 7 also showed the ability of EPCs to switch the differentiation 
process under specific conditions and confirmed that the lovastatin can stimulate the PECAM-
1 expression in endothelial cells. The gene expression data provide strong evidence for 
osteogenic transformation of the EPCs to osteoblasts on all scaffolds tested.  
 
 
Fig. 9. Quantitative PCR analysis of endothelial progenitor cells (EPCs) undergoing 
differentiation to osteoblasts. EPCs growing on 25% (w/w) PLGA1000-PEG1000-PLGA1000 (A); 
PLGA1000-PEG1000-PLGA1000 + lovastatin (B); PLGA1000-PEG1000-PLGA1000 +nanocrystalline 
diamonds (C); PLGA1000-PEG1000-PLGA1000 + lovastatin + nanocrystalline diamonds (D). 
Each assay was run in triplicate at three different template concentrations. Relative mRNA 
expression is normalized to ribosomal protein L7 (Rpl7), displayed relative to Day 1, and 
presented as a common log plot. 
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The tissue engineering is based on the method of cell seeding on scaffolds that play a role as 
a matrix to guide cell growth and to assist the formation of functional new tissues. Scaffolds 
grant this process by promoting an appropriate surface and sufficient spaces to favor the cell 
attachment, migration, proliferation and special differentiation in three dimensional ways. 
The design of the scaffold is the most important because it influences the above mentioned 
processes. There are many worldwide accepted criteria for ideal scaffolds with application 
in tissue engineering and the critical ones include the main material, mechanical properties, 
3D architecture, surface morphology and chemistry, as well as the scaffold environment 
before and after the degradation process (Wei G. & Ma P.X., 2007). Other important 
properties are: (1) to be biocompatible – non-immunogenic and (2) non-toxic for the living 
cells and tissue. To test the biocompatibility of the scaffolds prepared by us we have 
conducted the in vivo experiments.  
5.6 In vivo mass decrease of polymer hydrogels 
The 3D-scaffolds loaded with lovastatin and/or nanodiamods and injected in rats provide 
an evidence for biocompatibility and degradability. To examine time-dependent in vivo 
mass loss of polymer hydrogels, we prepared sterile 25% (w/w) PLGA1000-PEG1000-PLGA1000  
±  NCDs  ±  lovastatin and injected them into the rats, subcutaneously. Injectable hydrogels 
for biomedical applications should be degraded or eliminated from the body after 
accomplishment of their role. Fig. 10 shows in situ gel formation of a polymer solution and 
separated gels explanted at 2 time points. All polymer solutions transformed to hydrogels, 
and the hydrogels showed time-dependent mass decrease behaviors. 
 
 
Fig. 10. In vivo time-dependent mass decrease of polymer hydrogels. Photographs of 
separated polymer explants and in situ gelation of the polymer solutions from s.c. injected 
rats. 25% (w/w) PLGA1000-PEG1000-PLGA1000 (A); PLGA1000-PEG1000-PLGA1000 + lovastatin (B); 
PLGA1000-PEG1000-PLGA1000 +nanocrystalline diamonds (C); PLGA1000-PEG1000-PLGA1000 + 
lovastatin + nanocrystalline diamonds (D). 
The hydrogels containing PLGA1000-PEG1000-PLGA1000 alone showed the fastest mass decrease, 
but they still remained detectable within 4 weeks. The mass of the polymer hydrogels was 
decreased in the order of PLGA1000-PEG1000-PLGA1000 + NCDs ≅ PLGA1000-PEG1000-PLGA1000 + 
lovastatin + NCDs > PLGA1000-PEG1000-PLGA1000 + lovastatin > PLGA1000-PEG1000-PLGA1000. 
After 4 weeks, the remained masses of hydrogels were 59%, 58%, 48 and 23%, respectively. We 
also noticed that around 3 of the PLGA1000-PEG1000-PLGA1000 + lovastatin loaded hydrogels less 
capillaries were present, which can be attributed to the negative effect of lovastatin on 
endothelial cell proliferation and angiogenesis. It may also be connected with the difference of 
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environment, especially water content. There was no adverse effect during the in vivo tests. 
The observed results suggest that polymeric solutions ± NCDs and ± lovastatin can be used as 
injectable and biodegradable hydrogels and the degradation rate of the composites can be 
controlled by adjusting substituent compositions. 
Since the scaffolds with NCDs showed very good biocompatibility the next step was to test 
the opportunity for preparation of new, bio-enhanced UNCD containing films with 
potential application for implant preparation.  
5.7 ND film modifications and the role of implant functionalization  
The UNCD films deposited under the conditions described above have been 
comprehensively characterized with respect to their crystallinity, composition, topography 
and bonding structure (Popov et al., 2003; Popov et al., 2004; Popov C. & Kulisch W., 2003). 
The X-ray diffraction and selected area electron diffraction (Fig. 11A) revealed patterns 
characteristic for diamond phase. Furthermore, the size of the diamond crystallites was 
determined from the XRD peaks to be on the order of 3-5 nm. These nanocrystallites are 
embedded in an amorphous carbon matrix with a grain boundary width of 1.0-1.5 nm, as 
shown by TEM (Popov et al., 2004). The ratio of the volume fractions of the two phases- 
crystalline and amorphous - estimated from the density of the coatings and from the total 
crystallinity is close to unity (Popov et al., 2003). Investigations of the UNCD films with Raman 
spectroscopy, X-ray photoelectron spectroscopy (XPS), electron energy loss spectroscopy 
(EELS, Fig. 11B) and Auger electron spectroscopy (AES) showed the presence of sp2-bonded 
carbon atoms (up to 15 at%) localized in the amorphous matrix (Popov et al., 2003; Popov et 
al., 2004). Although no H2 was added to the precursor gas mixture, the UNCD films contain 
about 9-10 at% H in the bulk, as revealed by elastic recoil detection (ERD) analysis, originating 
from the CH4 molecules. Fourier transform infrared spectroscopy showed that hydrogen is 
bonded predominantly in sp3-CHx groups (Popov & Kulisch, 2003). 
 
 
Fig. 11. Physico-chemical characterization of the UNCD films. (A) Selected area electron 
diffraction of UNCD film; (B) Electron energy loss spectra of different carbon materials 
(Popov et al., 2004; Popov et al., 2011). 
www.intechopen.com
 
Osteoporosis: A Look at the Future 
 
685 
Atomic force microscopy (AFM) studies showed for all investigated samples the 
characteristic topography of UNCD films, composed of structures with diameters of several 
hundred nanometers, which themselves possess a substructure (Fig. 12A). The root mean 
square surface roughness values lie in the narrow range of 10 – 14 nm (Kulisch et al., 2011). 
The nanostructured surface can expect to enhance the attachment of cells on it. The surface 
composition of the as-grown UNCD films (AG in the following) was investigated by XPS. 
The results showed that the as-grown surfaces are very clean, with oxygen and nitrogen 
concentrations of about 2.0 and 1.0 at%, respectively. Nuclear reaction analysis (NRA) 
revealed the depth profiles of hydrogen concentration in the UNCD films and indicated 
surface H concentration of 12-14 at% (Fig. 12B)(Kulisch et al., 2008). 
 
 
Fig. 12. AFM image of the surface of UNCD film revealing the typical topography of the 
coatings (A) and Hydrogen depth distribution determined by nuclear reaction analysis  and  
scanning electron microscopy  cross section micrograph of UNCD film (B) (Kulisch et al., 
2008; Popov et al., 2003; Popov et al., 2011). 
The surface composition of UNCD films after different modifications, described above, has 
been also investigated by XPS (Popov et al., 2008b) and the results are summarized in Fig. 13A. 
As already mentioned, the surface of AG is very clean, the same holds for AR. The sample NP 
exhibits an increase of the surface nitrogen concentration from 1.0 to 7.4 at% after ammonia 
treatment (Koch et al., 2011). It was found that the oxygen content of the O2 plasma treated 
surface is about 12 at% (OP) and about 8.5 at% for the UV/O3 treated sample (UV), in contrast 
to 2.0 at% for AG, indicating an oxidation of the surface by both processes. The plasma 
treatment with CHF3 leads to a surface fluorine concentration of almost the same value (ca. 12 
at%) showing that a fluorination process has taken place on the surface. Having in mind that 
the hydrogen surface concentration of the as-grown samples is about 14 at% (Kulisch et al., 
2008), the XPS results indicate a change of the surface termination by the plasma processes. 
Closer analyses of the XPS peaks revealed that in the case of the oxygen plasma treatment the 
terminating hydrogen atoms are replaced by O and OH groups rather than by carboxylic acid 
groups (Popov et al., 2008b). CHF3 plasma treatment has led to a substitution of the C-H bonds 
by C-F rather than to the deposition of a CxHyFz polymer (Popov et al., 2008b). 
The wettability of the differently treated UNCD surfaces against purified water were 
examined by contact angles measurements. The results presented in Figs. 13B and 14 show 
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that all applied treatments have resulted in modification of the original surface. Three types of 
surfaces can be differentiated: hydrophobic (AG, HP, FP), hydrophilic (OP, NP, UV) and 
surface AR in between the two groups. The contact angles qC of the three highly hydrophobic 
samples are in the order AG < HP < FP varying between 85 and 100°, while all hydrophilic 
samples possess qC < 10°. The contact angle of AR is 67° showing also a hydrophobic character. 
 
 
Fig. 13. Surface composition of ultananocrystalline diamond/amorphous carbon composite 
films after different treatments (B – carbon; C- oxygen; D- nitrogen; E- fluorine) (A) and 
contact angles of same surfaces after different treatments (B) (Popov et al., 2011). 
 
 
Fig. 14. Contact angles and water droplet profiles on ultananocrystalline 
diamond/amorphous carbon composite films: as-grown (left), after F-containing plasma 
modification (middle) and after UV/O3 treatment (right) (Popov et al., 2011). 
The interaction of a surface with cells is usually dominated (at least in the initial stage) by 
adhesion of proteins onto the biomaterial surface, which occurs rather rapidly. For this 
reason it is important to study the interactions of proteins with UNCD surfaces and to tailor 
them, if necessary, by suitable surface modifications. Up to now, three series of experiments 
have been carried out to investigate the UNCD/protein interactions. 
In the first series, scanning force spectroscopy measurements have been performed with as-
grown UNCD films and glass (as a reference) onto which proteins have been deposited. A 
silicon cantilever functionalized with bovine serum albumin (BSA) has been used for this 
purpose. 120 single measurements at different positions have been performed for each of the 
two samples. On the UNCD sample none of 120 measurements indicated any interaction; all 
force curves had the structureless shape. In contrast, for the glass sample in 38% of all 
force/distance measurements an interaction between the BSA-functionalized cantilever and 
the surface was observed, which gave rise to force curves. Thus it can be concluded that the 
UNCD surfaces are not prone to unspecific interactions with proteins (Popov et al., 2007). 
On the other hand, even on such inactive surfaces there will be adhesion of highly fouling 
proteins such as BSA. In order to investigate whether the BSA adhesion on UNCD films is 
influenced by the surface termination, several of the above discussed surfaces have been 
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subjected to BSA exposure in the second series of experiments. Immediately after this exposure 
the surfaces were investigated by time of flight secondary ion mass spectroscopy (ToF-SIMS) 
and XPS (Kulisch et al., 2007). According to the ToF-SIMS analysis, all surfaces were covered 
by a BSA layer approaching a monolayer but it turned out to be impossible to quantify the 
adhesion and to evaluate differences between the various surfaces. More insight into this 
question was brought by XPS measurements. The surface composition of all samples 
investigated was far from that of a thick spin-coated BSA layer on a silicon substrate, taken as 
a reference, indicating that the BSA coverage on the UNCD surfaces is limited. As the 
composition of the starting surfaces is different as discussed above, it seems to be more useful 
to look at the compositional changes inferred by the BSA exposure which are shown in Fig. 
15A. From this figure it is evident that the changes of the surface composition of the as-grown 
AG surface are only marginal. They are more pronounced for the H2 and O2 plasma treated 
samples (HP and OP). The largest changes, and thus the highest adhesion of BSA, were 
observed for the chemically aqua regia treated surface AR. A possible reason is the partial loss 
of the hydrogen termination caused by the treatment as discussed above. Summarizing, it can 
be stated that the unspecific adhesion of biomolecules such as the highly fouling bovine serum 
albumin on UNCD surfaces can be influenced by the surface termination. 
In the third series of experiments, the protein adsorption on UNCD surfaces with different 
terminations was studied by inverted enzyme-linked immunosorbent assay (ELISA) with 
albumin and fibrinogen (Popov et al., 2009). The ratio of albumin to fibrinogen adsorption 
was calculated from the individual levels of both proteins adsorbed on the surfaces (Fig. 
15B). The oxygen terminated layers exhibit a higher albumin to fibrinogen ratio as compared 
with the fluorine and hydrogen terminated films. It has been pointed out that the variation 
of the albumin and fibrinogen adsorption ratio is strongly related to the associated surface 
energies since fibrinogen, being itself hydrophobic, preferentially adsorbs on hydrophobic 
surfaces, but albumin (with a hydrophilic nature) on hydrophilic surfaces during 
competitive binding. The O-terminated UNCD layers have a hydrophilic surface (33° 
contact angle against water), leading to a higher albumin/fibrinogen ratio. The F-terminated 
films show the lowest protein ratio, which is related to the hydrophobic nature of these 
surfaces (contact angle of water 91°). Therefore the albumin adsorption is much greater on 
the oxygen terminated surfaces and vice versa – the fibrinogen is preferentially adsorbed on 
the hydrophobic fluorine and hydrogen terminated surfaces. 
 
 
Fig. 15. Relative changes of the surface composition caused by the exposure of the samples 
to bovine serum albumin (A) and Contact angles and BSA/fibrinogen adsorption ratios on 
differently terminated UNCD surfaces (B) (Popov et al., 2011). 
The biocompatibility of UNCD films was studied by direct contact tests with osteoblast-like 
cells, fibroblasts and endothelia cells (Popov et al., 2006a; Popov et al., 2007; Popov et al., 
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2008a). All cells showed good adhesion and spreading on the UNCD surfaces following the 
incubation. After several days of cultivation they formed confluent monolayers; 
comparisons with cells from control samples showed that the UNCD films are not cytotoxic 
and do not affect the cell viability and proliferation.The coatings are also bioinert as 
revealed by simulated body fluid (SBF) tests. The exposure to SFB with a composition close 
to that of blood plasma for 10 days did not result in the formation of hydroxyapatite as 
shown by analyses of the SBF composition and of the film surface (Popov et al., 2006a). 
6. A look at the future 
Extraordinary progress has been made in the last decade towards the design of implants 
and scaffolds with a suitable multi-scale hierarchical structure. The limitations of the design 
of current bone implants arise mainly from the lack of firm quantitative mechanical data of 
bones in different stages of osteoporosis. Whilst it is known that osteoporotic bone is 
generally not cancellous in nature and has thin walls, the essential design paradigm of 
implants does not reflect this application. 
A simple system for assisted bone repair proposed is the in bone injection of “intelligent” 
polymers combined with progenitor cells. It utilizes autologous stem cells transplantation in 
combination with supportive bioresorbable matrices and bioactive molecules for enhancing 
growth and repair. Ideally, endothelial progenitor cells obtained from peripheral blood of 
the same patient may be cultured in vitro in the presence of different stimuli and/or 
nanoparticles to undergo osteoblasts differentiation, prior to autologous transplantation. 
This injectable therapy could also be used for: (1) modifying the bone interior morphology, 
porosity and interconnectivity, which are extremely important for cell adhesion, 
proliferation and differentiation; (2) prophylactic treatment for high risk patients to prevent 
fractures, especially the hip and vertebrae; (3) treatment to stabilize loose prostheses for 
patients who would soon require revision surgery; (4) providing exceptional repair of the 
osteoporotic bone by releasing pharmaceuticals to the specific sites with the purpose of 
accelerating healing, promoting angiogenesis, reducing the risk of infection, etc. 
The pursuit of effective treatments for osteoporotic disease is an extremely challenging 
scientific frontier requiring the integration of multiple engineering, biological, chemical, 
surgical, and pathophysiology related disciplines. It is also necessary to have a better 
understanding of molecular and cellular mechanisms specific to osteoporosis. Studying 
genomics, proteomics and diseases biology in parallel is likely to yield transformative 
insights in this regard. Our results together with the continuously incoming new data could 
have direct implications in the use of biomaterials in tissue engineering and in combination 
with the rapid manufacturing techniques will offer great opportunities to generate different 
scaffolds for bone engineering in near future.  
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number of different specialties are holding the scientific knowledge in osteoporosis. For this reason, we have
collected papers from scientific departments all over the world for this book. The book includes up-to-date
information about basics of bones, epidemiological data, diagnosis and assessment of osteoporosis,
secondary osteoporosis, pediatric issues, prevention and treatment strategies, and research papers from
osteoporotic fields.
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